Taiwan Bio Therapeutics , Ltd Total Liabilities

The latest total liabilities for 6892.TWO is $620M as of June 2026. That compares with $390M in the prior-year period — up 57.3% year over year. Investors often review this figure alongside Taiwan Bio Therapeutics , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6892.TWO's total liabilities moved from $390M to $620M — a 57.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Taiwan Bio Therapeutics , Ltd's operating scale or balance-sheet position.

A total liabilities figure of $620M for 6892.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6892.TWO's total liabilities ($620M), review year-over-year change from $390M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Taiwan Bio Therapeutics , Ltd's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.